晚间公告丨8月8日这些公告有看头

Group 1 - Chuangyuan Co., Ltd. announced that the impact of the current co-branded new products on the company's revenue and profit is limited in the short term [2] - Anke Biotech's subsidiary's PA3-17 injection has been included in the list of proposed breakthrough therapeutic products by the National Medical Products Administration, showing a high objective response rate of 84.6% in clinical trials [3] - Wanxing Technology plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance its global strategy and brand image [4] - Puyuan Precision plans to issue H-shares and list on the Hong Kong Stock Exchange, considering the interests of existing shareholders [5] Group 2 - Tianfu Communication's shareholder plans to transfer 1.27% of shares due to personal funding needs, with a transfer price set at 70% of the average stock price over the previous 20 trading days [6] - Huaguang Huaneng reported that its stock has seen a continuous increase of 46.44% over four trading days, with no significant changes in its fundamental operations [7] - Huali Group's controlling shareholder proposed a profit distribution plan for the first half of 2025, suggesting a cash dividend of 10 yuan per 10 shares [8] Group 3 - Shuangyi Technology reported a net profit of 99.87 million yuan for the first half of 2025, a year-on-year increase of 324.5%, driven by increased wind power installations [9] - Innovation Medical reported a revenue of 402 million yuan, with a net loss of 11.36 million yuan, showing a reduction in losses compared to the previous year [10] - Shuoshi Biotech's net profit decreased by 86.35% in the first half of 2025, with a proposed cash dividend of 34 yuan per 10 shares [11] - Furi Electronics achieved a net profit of 22.08 million yuan, turning around from a loss of 93.51 million yuan in the previous year, attributed to improved gross margins in its LED display business [12] Group 4 - Shiyun Circuit's major shareholder plans to reduce its stake by up to 3% within three months [13] - Henggong Precision's shareholder intends to reduce its stake by up to 3% through various trading methods [14]